R&D
JW, leading global new drug development
Research Center
Research center status
JW Sinyak has incorporated JW creagene as its subsidiary in 2009, leading the development of new immune - based treatments.
JW CreageneSungnam-si, Gyeonggi
Core foundation technique : Immune cell vaccine
- Dendritic cell vaccine
- Cytoplasmic transduction peptide technology (CTP)
- Protein manufacturing techniques